Citius Pharmaceuticals Inc.
13F holders, Q4 2024 (December 31)1holders −57
0new positions
34sold out
$0.13avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Citius Pharmaceuticals Inc. in their 13F filings, down 57 from Q3 2024. 0 opened new positions and 34 sold out. The largest holder was IFP Advisors, Inc ($4K).
- Company
- Citius Pharmaceuticals Inc.
- CUSIP
- 17322U207
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 34 | $4.7M |
All 13F filers, Q3 2024 → Q4 2024: 9,325,876 shares sold, net −9,325,876 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | No change | 33,333 | $4K |
"% of holder's portfolio" is CITIUS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Citius Pharmaceuticals Inc. the manager owns.